Read more about the article 7 Ways to Increase Clinical Trial Patient Engagement with SMS & Messaging Apps
hybrid clinical trials | Delve Health

7 Ways to Increase Clinical Trial Patient Engagement with SMS & Messaging Apps

Most of us agree that a clinical trial’s success depends heavily on patient engagement. The importance of design patient-centric studies cannot be understated. Engaged patients make for successfully completed studies—with…

Continue Reading7 Ways to Increase Clinical Trial Patient Engagement with SMS & Messaging Apps
Read more about the article The Rise of eConsent Forms and its Impact on Patient Recruitment
Delve Health's eConsent tools use multi-media platforms.

The Rise of eConsent Forms and its Impact on Patient Recruitment

Informed consent is one of the founding principles of research ethics. Its intent is that human participants can partake in medical research freely (i.e., voluntarily) with full information about what it…

Continue ReadingThe Rise of eConsent Forms and its Impact on Patient Recruitment

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around

A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials…

Continue ReadingDelve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around
Read more about the article Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials
Screen Shot Clinical researcher| Delve Health

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The article's text is below, but you can…

Continue ReadingOpinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials